Better MRI Clues Help Diagnose MS in Asian Patients

Credibility

Interest

Key Takeaway

Combining MRI signs called the central vein sign, paramagnetic rim lesions, and cortical lesions helps tell multiple sclerosis (MS) apart from similar diseases in Asian patients, especially those under 70.

What They Found

Researchers looked at brain MRIs from Japanese patients with MS and two similar conditions (NMOSD and MOGAD). They found at least one central vein sign (a small vein seen in a lesion) in most MS patients (95%), but also in some patients with other diseases. Paramagnetic rim lesions (dark rims on certain MRI scans that suggest ongoing damage) were seen only in people with MS (63% of MS patients). Using a rule that counts how many lesions have a central vein (two or more) correctly identified MS about 86% of the time and correctly excluded other diseases about 76% of the time. When the central vein count or a selection method called Select 6 was combined with paramagnetic rim lesions and cortical lesions (lesions on the brain surface), the tests got much better at telling MS apart from the other diseases, especially in people under 50 or under 70.

Who Should Care and Why

People with MS or suspected MS and their caregivers should care because this study suggests MRI features can make diagnosis more accurate, which affects treatment choices and planning. Think of it like using several clues together—like fingerprints, a shoe print, and a witness—to be more sure who did something; combining MRI signs gives a clearer answer than any single sign. Neurologists and radiologists who treat or image people with MS will benefit because these combined signs can help them make better, faster diagnoses. Families may notice this changes how quickly a treatment plan starts, which can help manage symptoms and reduce future disability. Patients with uncertain diagnoses or those from Asian backgrounds may especially benefit because the research focused on how these MRI clues work in this population.

Important Considerations

This study used MRI scans from one country and may not represent every Asian group or all MRI machines and settings, so results might differ elsewhere. Some MRI signs also appear in other diseases, so doctors still need to use tests, history, and exams together—these MRI clues are helpful but not perfect. The findings were strongest in younger patients, so the tests are less certain for older people and should be interpreted with extra caution.

Categories:

MS Diagnostics Clinical Trials MS Progression

Article Topics:

AsianMultiple sclerosiscentral vein signcortical lesiondiagnosisparamagnetic rim lesion

Whether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Multiple sclerosis (Houndmills, Basingstoke, England) often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.

However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.

By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.

Back to News